Research Article
Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population
Table 3
AUC and cutoff value of plasma fibulin-3 for diagnosing ARDs.
| | AUC (95% CI) | Cutoff value (ng/ml) | Sensitivity (%) | Specificity (%) | value |
| MPM versus control | 0.92 (0.81–1.00) | 15.30 | 86.67 | 97.87 | <0.001 | MPM versus AE | 0.88 (0.75–1.00) | 15.84 | 86.67 | 91.89 | <0.001 | MPM versus PP | 0.90 (0.78–1.00) | 15.86 | 86.67 | 93.58 | <0.001 | MPM versus asbestosis | 0.81 (0.67–0.96) | 15.69 | 86.67 | 75.86 | 0.001 | Asbestosis versus controls | 0.67 (0.55–0.79) | 14.88 | 31.03 | 97.87 | 0.007 | AE versus controls | 0.61 (0.53–0.70) | 12.26 | 41.89 | 77.66 | 0.014 | PP versus controls | 0.57 (0.50–0.64) | 8.40 | 90.83 | 23.40 | 0.040 |
|
|
AUC: area under the curve; CI: confidence interval; PP: pleural plaque; MPM: malignant pleural mesothelioma; AE: asbestos-exposed subjects; ARDs: asbestos-related diseases.
|